Document is current
Any future updates will be listed below
-
Authors
Sobrino-García, Miriam https://orcid.org/0000-0002-8644-8441
Muñoz-Bellido, Francisco J. https://orcid.org/0000-0003-4071-9928
Moreno-Rodilla, Esther https://orcid.org/0000-0003-0953-3025
Martín-Muñoz, Rita
García-Iglesias, Aránzazu
Dávila, Ignacio https://orcid.org/0000-0001-8485-5513
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (JR22/00050)
- License Information
-
More Information
Article History
Received: 1 November 2023
Accepted: 4 April 2024
First Online: 20 April 2024
Conflicts of interest
: Ignacio Dávila, In the last three years, has received payment for lectures, including service on speaker’s bureaus from Allergy Therapeutics, Astra-Zeneca, Chiesi, Diater, GSK, Leti, Novartis, Sanofi; for a consultancy from Allergy Therapeutics, ALK-Abello, Astra-Zeneca, GSK, Merck, MSD, Novartis, Sanofi; and grants for Thermofisher Diagnostics, ISCIII and Junta de Castilla y León. Francisco J. Muñoz-Bellido, Esther Moreno-Rodilla, Rita Martín-Muñoz and Aránzazu García-Iglesias have no conflicts of interest to declare.
